Testing effectiveness (Phase 2)WithdrawnNCT04138875
What this trial is testing
A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)
Who this might be right for
PTLDLymphoid TumorHematopoietic/Lymphoid Cancer+6 more
Yale University